Does NILOTINIB Cause Peripheral arterial occlusive disease? 319 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 319 reports of Peripheral arterial occlusive disease have been filed in association with NILOTINIB (nilotinib). This represents 1.4% of all adverse event reports for NILOTINIB.
319
Reports of Peripheral arterial occlusive disease with NILOTINIB
1.4%
of all NILOTINIB reports
34
Deaths
83
Hospitalizations
How Dangerous Is Peripheral arterial occlusive disease From NILOTINIB?
Of the 319 reports, 34 (10.7%) resulted in death, 83 (26.0%) required hospitalization, and 10 (3.1%) were considered life-threatening.
Is Peripheral arterial occlusive disease Listed in the Official Label?
Yes, Peripheral arterial occlusive disease is listed as a known adverse reaction in the official FDA drug label for NILOTINIB.
What Other Side Effects Does NILOTINIB Cause?
Death (2,667)
Fatigue (1,679)
Rash (1,250)
Nausea (1,180)
Headache (1,177)
Pain (1,169)
Dyspnoea (1,070)
Diarrhoea (998)
Drug ineffective (992)
Malaise (961)
What Other Drugs Cause Peripheral arterial occlusive disease?
METHOTREXATE (120)
ADALIMUMAB (116)
RIVAROXABAN (101)
PONATINIB (90)
IMATINIB (86)
ASPIRIN (77)
ATORVASTATIN (70)
METOPROLOL (70)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (63)
ETELCALCETIDE (63)
Which NILOTINIB Alternatives Have Lower Peripheral arterial occlusive disease Risk?
NILOTINIB vs NIMESULIDE
NILOTINIB vs NIMODIPINE
NILOTINIB vs NINTEDANIB
NILOTINIB vs NINTEDANIB ESYLATE
NILOTINIB vs NIRAPARIB